All product features corresponded with the valid specifications of the (b)(4) at the time, when the item was produced.
A damage pattern as in the present case is known from cases of damage after functional overload of the components due to obese constitution of patient and insufficient soft tissue tension.
The report is delayed due to inconsistencies with regard to foreign event reporting to fda.
After re-evaluation of the complaint we determined that it is reportable.
We have addressed the inconsistency in reporting foreign events to fda through capa (b)(4).
|